Debi Boeras, chief executive officer at the Global Health Impact Group, is a virologist and molecular biologist with almost 20 years experience in global health and laboratory medicine. Debi’s work has focused on bringing new diagnostics and testing strategies to low- and middle-income countries with an emphasis on quality assurance and strengthening health systems and laboratory networks.